Keyphrases
Dermatomyositis
100%
Tongue Drive System
92%
Nephrogenic Systemic Fibrosis
82%
United States
75%
Body piercing
70%
Psoriasis
61%
Tongue
54%
Melanoma
51%
Electric Wheelchair
46%
Spinal Cord Injury
42%
Morphea
40%
Primary Cutaneous Melanoma
40%
Percutaneous Absorption
40%
People with Tetraplegia
40%
Multiple Primary
40%
Non-melanoma Skin Cancer
40%
Levodopa
40%
Epidermis
33%
Malignant Melanoma
32%
Gadolinium-based Contrast Agents
32%
Hairless Mice
30%
Systemic Lupus Erythematosus
30%
Cancer-related
30%
Odds Ratio
29%
Smartphone
27%
ICD-9
27%
Tongue piercing
26%
Piercing
26%
Sun Protection
26%
Early Treatment
26%
Epidermal Proliferation
26%
Confidence Interval
26%
Assistive Technology
26%
Renal Disease
26%
Tumor
25%
Fibrosis
25%
Educational Materials
25%
Barbell
24%
Systemic Infection
22%
Juvenile Dermatomyositis
22%
Adverse Drug Events
22%
Aftercare
22%
Body Art
22%
Systemic Lupus
20%
Tolerability
20%
Algae Toxins
20%
Blood Type
20%
Debromoaplysiatoxin
20%
Medical Tattoo
20%
Marine Algae
20%
Medicine and Dentistry
Tattoo
80%
Tongue
80%
Dermatomyositis
66%
Melanoma
62%
Body Piercing
60%
Nephrogenic Systemic Fibrosis
48%
Tattooing
40%
Drive
40%
Levodopa
40%
Cutaneous Melanoma
40%
Tetraplegia
40%
Non Melanoma Skin Cancer
40%
Odds Ratio
39%
Prevalence
35%
Infection
33%
Diseases
29%
Assistive Technology
28%
Malignant Neoplasm
26%
Pediatrics
26%
Psoriasis Vulgaris
26%
Sun Protection
26%
Lupus Vulgaris
26%
Psoriasis
26%
Health Care Cost
25%
Tongue Piercing
24%
ICD-9
24%
Squamous Cell Carcinoma
24%
Sepsis
24%
Juvenile Dermatomyositis
22%
Kidney Function
22%
International Classification of Diseases
22%
Spinal Cord Injury
21%
Logistic Regression Analysis
20%
Acquired Immune Deficiency Syndrome
20%
Cylindroma
20%
Onycholysis
20%
Medical Device
20%
Ustekinumab
20%
Randomized Clinical Trial
20%
Discoid Lupus Erythematosus
20%
Tyrosine-Kinase Inhibitor
20%
Diffuse Large B-Cell Lymphoma
20%
B-Cell Lymphoma
20%
Cohort Analysis
20%
Human Immunodeficiency Virus
20%
Diagnosis of Alzheimer's Disease
20%
Cardiovascular System
20%
Nickel Hypersensitivity
20%
Cosmetics
20%
Sorafenib
20%